Acute Care Kit
- Manufacturer
- MARPE LLC | OHM PHARMA INC.
- Effective date
- 2014-04-30
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:05:41
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS (HPUS*): ACONITUM NAPELLUS 30C, ANTIMONIUM TARTARICUM 30C, APIS MELLIFICA 30C, APIS MELLIFICA 200C, ARNICA MONTANA 30C, ARNICA MONTANA 200C, ARSENICUM ALBUM 30C, BELLADONNA 30C, CANTHARIS 30C, CARBO VEGETABILIS 30C, CARBO VEGETABILIS 200C, CHAMOMILLA 30C, CHINA OFFICINALIS 30C, GELSEMIUM SEMPERVIRENS 30C, HEPAR SULPHURIS CALCAREUM 30C, HYPERICUM PERFORATUM 30C, IPECACUANHA 30C, KALI BICHROMICUM 30C, LACHESIS MUTUS 30C, LYCOPODIUM CLAVATUM 30C, NUX VOMICA 30C, PHOSPHORUS 30C, PULSATILLA 30C, RHUS TOXICODENDRON 30C, URTICA URENS 30C.
OTHER SAFETY INFORMATION
* The letters “HPUS” indicate that the components in this product are officially monographed in the Homoeopathic Pharmacopoeia of the United States.
INDICATIONS & USAGE SECTION
USES: See the included remedy guide for more information.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS: Adults/Children: Dissolve 3-5 pellets in mouth 3 times a day for up to 7 days or as directed by a health care practitioner.
WARNINGS SECTION
WARNING:
Do not use if seal is broken. If you are pregnant or nursing, consult your health care practitioner before use. Store in a cool, dry place. If symptoms persist or worsen, discontinue use and contact a licensed health care practitioner.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF THE REACH OF CHILDREN.
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENT: Sucrose. Lactose - free.
OTC - QUESTIONS SECTION
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
- NDC: 62990-690-18
Nature Kits by Marpe
ACUTE CARE KIT
Dr. Brown's Top Remedies for First Aid and Self Limiting Conditions
- 25 HOMEOPATHIC MEDICINES



OTC - PURPOSE SECTION
Dr. Brown's Top Remedies for First Aid and Self Limiting Conditions
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 63f39a63-5cd1-4016-bd86-2bbb0f6c3139 | Product name | 3 | 20240506 |
| e5a77e9c-c528-733a-173d-914a234c024b | Product name | 5 | 20240506 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62990-690-18 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3618-60a7-e053-dbdaa90a05bd | ACUTE CARE KIT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62990-690-18 | Acute Care Kit | 25 in 1 KIT | PELLET | 25 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62990-690 | ACUTE CARE KIT (ACONITUM NAPELLUS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, CANTHARIS, CARBO VEGETABILIS, CHAMOMILLA, CINCHONA, GELSEMIUM, HEPAR SULPH CALCAREUM, HYPERICUM PERFORATURM, IPECACUANHA, KALI BICHROMICUM, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORUS, PULSATILLA, RHUS TOXICODENDRON, URTICA URENS) PELLET [MARPE LLC] | 2 | Legacy NDC, 1 package rows | 20140501_fd964c61-4ab4-4865-8607-811c4d394030.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACONITUM NAPELLUS | ACTIVE INGREDIENT | U0NQ8555JD | 2 | |
| ACTIVATED CHARCOAL | ACTIVE INGREDIENT | 2P3VWU3H10 | 2 | |
| ANTIMONY POTASSIUM TARTRATE | ACTIVE INGREDIENT | DL6OZ476V3 | 2 | |
| APIS MELLIFERA | ACTIVE INGREDIENT | 7S82P3R43Z | 2 | |
| ARNICA MONTANA | ACTIVE INGREDIENT | O80TY208ZW | 2 | |
| ARSENIC TRIOXIDE | ACTIVE INGREDIENT | S7V92P67HO | 2 | |
| ATROPA BELLADONNA | ACTIVE INGREDIENT | WQZ3G9PF0H | 2 | |
| CALCIUM SULFIDE | ACTIVE INGREDIENT | 1MBW07J51Q | 2 | |
| CINCHONA OFFICINALIS BARK | ACTIVE INGREDIENT | S003A158SB | 2 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE INGREDIENT | 639KR60Q1Q | 2 | |
| HYPERICUM PERFORATUM | ACTIVE INGREDIENT | XK4IUX8MNB | 2 | |
| IPECAC | ACTIVE INGREDIENT | 62I3C8233L | 2 | |
| LACHESIS MUTA VENOM | ACTIVE INGREDIENT | VSW71SS07I | 2 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE INGREDIENT | C88X29Y479 | 2 | |
| LYTTA VESICATORIA | ACTIVE INGREDIENT | 3Q034RO3BT | 2 | |
| MATRICARIA RECUTITA | ACTIVE INGREDIENT | G0R4UBI2ZZ | 2 | |
| PHOSPHORUS | ACTIVE INGREDIENT | 27YLU75U4W | 2 | |
| POTASSIUM DICHROMATE | ACTIVE INGREDIENT | T4423S18FM | 2 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 2 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE INGREDIENT | 269XH13919 | 2 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE INGREDIENT | 6IO182RP7A | 2 | |
| URTICA URENS | ACTIVE INGREDIENT | IHN2NQ5OF9 | 2 | |
| ACONITUM NAPELLUS | ACTIVE MOIETY | U0NQ8555JD | 2 | |
| ACTIVATED CHARCOAL | ACTIVE MOIETY | 2P3VWU3H10 | 2 | |
| ANTIMONY CATION (3+) | ACTIVE MOIETY | 069647RPT5 | 2 | |
| APIS MELLIFERA | ACTIVE MOIETY | 7S82P3R43Z | 2 | |
| ARNICA MONTANA | ACTIVE MOIETY | O80TY208ZW | 2 | |
| ARSENIC CATION (3+) | ACTIVE MOIETY | C96613F5AV | 2 | |
| ATROPA BELLADONNA | ACTIVE MOIETY | WQZ3G9PF0H | 2 | |
| CALCIUM SULFIDE | ACTIVE MOIETY | 1MBW07J51Q | 2 | |
| CINCHONA OFFICINALIS BARK | ACTIVE MOIETY | S003A158SB | 2 | |
| DICHROMATE ION | ACTIVE MOIETY | 9LKY4BFN2V | 2 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE MOIETY | 639KR60Q1Q | 2 | |
| HYPERICUM PERFORATUM | ACTIVE MOIETY | XK4IUX8MNB | 2 | |
| IPECAC | ACTIVE MOIETY | 62I3C8233L | 2 | |
| LACHESIS MUTA VENOM | ACTIVE MOIETY | VSW71SS07I | 2 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE MOIETY | C88X29Y479 | 2 | |
| LYTTA VESICATORIA | ACTIVE MOIETY | 3Q034RO3BT | 2 | |
| MATRICARIA RECUTITA | ACTIVE MOIETY | G0R4UBI2ZZ | 2 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | 2 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 2 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE MOIETY | 269XH13919 | 2 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE MOIETY | 6IO182RP7A | 2 | |
| URTICA URENS | ACTIVE MOIETY | IHN2NQ5OF9 | 2 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 2 |
Products#
Every source-derived product name is available through these pages.
- Acute Care Kit
- Aconitum Napellus, Antimonium Tartaricum, Apis Mellifica, Arnica Montana, Arsenicum Album, Belladonna, Cantharis, Carbo Vegetabilis, Chamomilla, Cinchona, Gelsemium, Hepar Sulph Calcareum, Hypericum Perforaturm, Ipecacuanha, Kali Bichromicum, Lachesis Mutus, Lycopodium Clavatum, Nux Vomica, Phosphorus, Pulsatilla, Rhus Toxicodendron, Urtica Urens
- ACONITUM NAPELLUS
- ANTIMONY POTASSIUM TARTRATE
- ANTIMONY CATION (3+)
- APIS MELLIFERA
- ARNICA MONTANA
- ARSENIC TRIOXIDE
- ARSENIC CATION (3+)
- ATROPA BELLADONNA
- LYTTA VESICATORIA
- ACTIVATED CHARCOAL
- MATRICARIA RECUTITA
- CINCHONA OFFICINALIS BARK
- GELSEMIUM SEMPERVIRENS ROOT
- CALCIUM SULFIDE
- HYPERICUM PERFORATUM
- IPECAC
- POTASSIUM DICHROMATE
- DICHROMATE ION
- LACHESIS MUTA VENOM
- LYCOPODIUM CLAVATUM SPORE
- STRYCHNOS NUX-VOMICA SEED
- PHOSPHORUS
- PULSATILLA VULGARIS
- TOXICODENDRON PUBESCENS LEAF
- URTICA URENS
- SUCROSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62990-690 | 62990-690-18 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUPPOSITORY / RECTAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION / SUBCUTANEOUS | 47.75 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 1 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | 1255 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b76a0c0a-cd16-4ff6-b17e-9a42b11ab6f6 | fd964c61-4ab4-4865-8607-811c4d394030 | 2014-04-30 | Warnings | b76a0c0a-cd16-4ff6-b17e-9a42b11ab6f6 fd964c61-4ab4-4865-8607-811c4d394030 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.